Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of Dexibuprofen 300mg in Healthy Volunteers
NCT02956512Phase 1Completed
- Sponsor
- Apsen Farmacêutica
- Start
- Mar 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dexibuprofen in pain (2 arms), sponsored by Apsen Farmacêutica. Primary endpoint: Adverse Events at 40 days. Started Mar 2019; status: completed.
02
Drugs
dexibuprofen
03
Conditions
pain
Beyond the preview
Go deeper on NCT02956512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02956512.